Not Yet Recruiting OBSERVATIONAL NCT06377774

To Optimize Therapeutic Procedures of DPMAS in ACLF Patients: a Prospective, Sigle Arm and Multicenter Study

To Optimize Therapeutic Procedures of Double-plasma Molecular Absorption System Therapy in acute-on Chronic Liver Failure Patients: a Prospective, Sigle Arm and Multicenter Study

Sponsor: Nanfang Hospital, Southern Medical University

Conditions Acute-On-Chronic Liver Failure

Interventions No intervention in this study

Updated 3 times since 2024 Last updated: Apr 17, 2024 Started: May 1, 2024 Primary completion: Mar 30, 2025 Completion: Feb 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06377774, this observational or N/A phase trial focuses on Acute-On-Chronic Liver Failure and remains actively recruiting participants. Sponsored by Nanfang Hospital, Southern Medical University, it has been updated 3 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
May 2024 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nanfang Hospital, Southern Medical University

Data source: Nanfang Hospital, Southern Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.